Caplin Point Laboratories rises with its arm getting into license & deliver agreement with Baxter

Caplin Point Laboratories rises with its arm getting into license & deliver agreement with Baxter

by admin- Monday, April 8th, 2019 04:15:39 PM

Caplin Point Laboratories is currently buying and selling at Rs. 395.00, up through 7.70 points or 1.99% from its previous remaining of Rs. 387.30 on the BSE.

The scrip opened at Rs. 388.Forty and has touched a excessive and coffee of Rs. 397.95 and Rs. 388.00 respectively. So a long way 1162 stocks had been traded at the counter.

The BSE organization ‘B’ stock of face price Rs. 2 has touched a 52 week excessive of Rs. 622.55 on 06-Apr-2018 and a fifty two week low of Rs. 304.Seventy five on 29-Jan-2019.

Last one week high and occasional of the scrip stood at Rs. 412.00 and Rs. 386.00 respectively. The current market cap of the business enterprise is Rs. 2974.Sixteen crore.

The promoters maintaining in the enterprise stood at 69.05%, whilst Institutions and Non-Institutions held 7.Eleven% and 23.Eighty four% respectively.

Caplin Point Laboratories’ totally owned Subsidiary — Caplin Steriles has entered right into a license and deliver settlement with Baxter Healthcare Corporation for 5 everyday injectable ANDAs.

News Updates